Antidepressant may stop the need to shop
The Rochester (N.Y.) Democrat and Chronicle
Stanford University researchers are studying whether a pill can squash the urge to splurge.
The drug - sold under such trade names as Celexa, Cipramil and Seropram - is a member of the newest class of antidepressants called selective serotonin reuptake inhibitors.
Not everyone is buying the findings.
"I think it's bogus," says Laurence Guttmacher, chief of psychiatry at the Rochester (N.Y.) Psychiatric Center. "If it's a prospective trial and if there's a placebo control, then I start to get impressed. Absent that, frankly, there's nothing really to hang your hat on."
Study leader Lorrin Koran, a professor of psychiatry and director of Stanford's Obsessive-Compulsive Disorder Clinic, will be double-blinding a second trial this year to put that control in place.
Neither the doctor nor the volunteers will know whose medication has been replaced with a placebo, preventing patients from improving simply based on their expectations.